Showing results (481-490 of 870) with videos related to

Sort By:
Pageof 87
Neuro-Degenerative Diseases|August 16, 2006
Tissue plasminogen activator-induced ischemic injury is reversed by NMDA antagonist MK-801 in vivoErtugrul Kilic, Ulkan Kilic, Mathias Bahr, et al.
Neuro-Degenerative Diseases|August 16, 2006
The long processes of short interfering RNAs--RNA interference and its implications in neuronal cellsPaul Lingor, Uwe Michel, Mathias Bähr
Neuro-Degenerative Diseases|August 16, 2006
Changes in dopamine D2 receptors and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake in the brain of 6-hydroxydopamine-lesioned ratsYasushi Ishida, Keiichi Kawai, Yasuhiro Magata, et al.
Neuro-Degenerative Diseases|August 16, 2006
Developing novel immunogens for an effective, safe Alzheimer's disease vaccineMarcel Maier, Timothy J Seabrook, Cynthia A Lemere
Neuro-Degenerative Diseases|August 16, 2006
APP processing and the APP-KPI domain involvement in the amyloid cascadeM Menéndez-González, P Pérez-Pinera, M Martínez-Rivera, et al.
Neuro-Degenerative Diseases|June 13, 2009
Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluidHillevi Englund, Malin Degerman Gunnarsson, Rose Marie Brundin, et al.
Neuro-Degenerative Diseases|December 11, 2008
Mitochondrial tRNALeu/Lys and ATPase 6/8 gene variations in spinocerebellar ataxiasSepideh Safaei, Massoud Houshmand, Mohammad Mehdi Banoei, et al.
Neuro-Degenerative Diseases|December 11, 2008
Plasma urate and progression of mild cognitive impairmentMichael C Irizarry, Rema Raman, Michael A Schwarzschild, et al.
Neuro-Degenerative Diseases|December 11, 2008
Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic miceLaurence Ozmen, Anita Albientz, Christian Czech, et al.
Neuro-Degenerative Diseases|March 21, 2009
MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degenerationJennifer L Whitwell, Clifford R Jack, Matthew L Senjem, et al.
Pageof 87